{
  "trial_id": "NCT00498719",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "age",
      "label": "met",
      "evidence": "16-year-old"
    },
    {
      "criterion": "school_status",
      "label": "met",
      "evidence": "enrolled in school or homebound instruction"
    },
    {
      "criterion": "diagnosis",
      "label": "not_met",
      "evidence": "myasthenia gravis, class IIa"
    },
    {
      "criterion": "treatment_status",
      "label": "met",
      "evidence": "within 2 months to 14 months after beginning treatment for cancer"
    },
    {
      "criterion": "iq",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "language",
      "label": "met",
      "evidence": "English-speaking"
    }
  ],
  "exclusion": [
    {
      "criterion": "physical_condition",
      "label": "not_met",
      "evidence": "BP: 110/75, Hgb: 11 g/dl, WBC: 8000 /mm3, Plt: 300000 /ml"
    },
    {
      "criterion": "neurologic_condition",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "psychiatric_condition",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "Patient is a 16-year-old girl with myasthenia gravis, class IIa. She has some symptoms despite treatment.",
  "_meta": {
    "topic_id": "72",
    "trial_id": "NCT00498719",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}